Axcella Health Long Term Debt Current 2011-2025 | AXLA

Annual Long Term Debt Current Axcella Health

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
1.59 M	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.59 M	1.59 M	1.59 M

Long Term Debt Current of other stocks in the Biotechnology industry

Issuer	Long Term Debt Current	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	3.63 M	-	2.43 %	$ 254 M	Germany
Arbutus Biopharma Corporation ABUS	425 K	$ 4.76	-0.73 %	$ 790 M	Canada
Aclaris Therapeutics ACRS	481 K	$ 3.01	-1.15 %	$ 233 M	USA
Aeglea BioTherapeutics AGLE	625 K	-	-	$ 1.01 B	USA
Alpine Immune Sciences ALPN	756 K	-	-	$ 2.17 B	USA
AlloVir ALVR	10.8 M	-	4.14 %	$ 49.1 M	USA
Aptorum Group Limited APM	433 K	$ 1.16	-0.85 %	$ 6.33 M	China
Ampio Pharmaceuticals AMPE	274 K	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	4.64 M	-	-	$ 10.1 M	USA
Ascendis Pharma A/S ASND	14.2 M	$ 209.37	-1.62 %	$ 5 B	Danmark
Aptevo Therapeutics APVO	800 K	$ 0.52	-44.08 %	$ 144 K	USA
Alterity Therapeutics Limited ATHE	57.6 K	$ 3.29	6.3 %	$ 7.92 B	Australia
BioVie BIVI	74.5 K	$ 1.16	-8.66 %	$ 1.71 M	USA
Athersys ATHX	1.01 M	-	3.77 %	$ 22.4 M	USA
ARCA biopharma ABIO	213 K	-	1052.0 %	$ 415 M	USA
AVROBIO AVRO	878 K	-	1083.1 %	$ 745 M	USA
Acasti Pharma ACST	75 K	-	4.01 %	$ 150 M	Canada
Adaptimmune Therapeutics plc ADAP	5.38 M	-	-15.15 %	$ 60.3 M	Britain
Albireo Pharma ALBO	3.08 M	-	-0.23 %	$ 916 M	USA
BioNTech SE BNTX	39.5 M	$ 94.21	-0.86 %	$ 27.2 B	Germany
Amphastar Pharmaceuticals AMPH	6.8 M	$ 27.0	0.7 %	$ 1.31 B	USA
BeiGene, Ltd. BGNE	17.6 M	-	0.49 %	$ 251 B	Cayman-islands
Can-Fite BioPharma Ltd. CANF	43 K	$ 0.22	24.23 %	$ 479 M	Israel
Anika Therapeutics ANIK	1.6 M	$ 9.49	0.11 %	$ 139 M	USA
Bellicum Pharmaceuticals BLCM	11 M	-	-9.72 %	$ 5.89 M	USA
Berkeley Lights BLI	3.29 M	-	-7.31 %	$ 87 M	USA
bluebird bio BLUE	21.2 M	-	-	$ 546 M	USA
Acer Therapeutics ACER	104 K	-	2.71 %	$ 14 M	USA
Calithera Biosciences CALA	1.37 M	-	-10.95 %	$ 876 K	USA
Axon Enterprise AXON	9.45 M	$ 583.31	-1.33 %	$ 44.2 B	USA
Ayala Pharmaceuticals AYLA	419 K	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	137 K	$ 2.47	-2.37 %	$ 15.5 M	USA
AstraZeneca PLC AZN	339 M	$ 92.76	0.34 %	$ 96.9 B	Britain
Acorda Therapeutics ACOR	1.59 M	-	-24.86 %	$ 820 K	USA
Catalyst Biosciences CBIO	210 K	$ 12.37	-	$ 814 M	USA
Brickell Biotech BBI	49 K	-	-5.38 %	$ 6.06 M	USA
Biohaven Pharmaceutical Holding Company Ltd. BHVN	675 K	$ 10.71	-0.88 %	$ 693 M	USA
Celldex Therapeutics CLDX	1.45 M	$ 26.13	-2.63 %	$ 1.68 M	USA
Biogen BIIB	86.4 M	$ 176.07	-0.15 %	$ 25.6 B	USA
Cellectar Biosciences CLRB	59 K	$ 2.55	-7.47 %	$ 31.2 M	USA
Cerevel Therapeutics Holdings CERE	3.4 M	-	-	$ 7.29 B	USA